Takeda's Zasocitinib Shows Promising Phase III Results for Psoriasis, Signaling a Potential Breakthrough
Massachusetts' Biopharma Giant, Takeda, Announces Significant Layoffs Impacting 137 Employees in Cambridge Amidst Industry Restructuring